Vitrasert
Active Ingredient(s): GanciclovirFDA Approved: * March 4, 1996
Pharm Company: * BAUSCH AND LOMB
Category: Antiviral
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections. Ganciclovir was patented in 1980 and approved for medical use in 1988.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 See also 6 References 7 Further reading 8 External links Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.